AJIC: American Journal of Infection Control
Volume 38, Issue 9 , Pages 751-753 , November 2010

Patients with Acinetobacter baumannii bloodstream infections are colonized in the gastrointestinal tract with identical strains

References 

  1. Lee NY, Lee HC, Ko NY, Chang CM, Shih HI, Wu CJ, et al. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Infect Control Hosp Epidemiol. 2007;28:713–719
  2. Villegas MV, Hartstein AI. Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol. 2003;24:284–295
  3. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 16th informational supplement (M100-S16). Wayne, PA: Clinical and Laboratory Standards Institute; 2006;
  4. Ecker JA, Massire C, Hall TA, Ranken R, Pannella TT, Agasino IC, et al. Identification of Acinetobacter species and genotyping of Acinetobacter baumannii by multilocus PCR and mass spectrometry. J Clin Microbiol. 2006;44:2921–2932
  5. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233–2239
  6. Corbella X, Pujol M, Ayats J, Sendra M, Ardanuy C, Domínguez MA, et al. Relevance of digestive tract colonization in the epidemiology of nosocomial infections due to multiresistant Acinetobacter baumannii. Clin Infect Dis. 1996;23:329–334
  7. Ayats J, Corbella X, Ardanuy C, Domínguez MA, Ricart A, Ariza J, et al. Epidemiological significance of cutaneous, pharyngeal, and digestive tract colonization by multiresistant Acinetobacter baumannii in ICU patients. J Hosp Infect. 1997;37:287–295
  8. Lortholary O, Fagon JY, Buu Hoi A, Mahieu G, Gutmann L. Colonization by Acinetobacter baumanii in intensive care unit patients. Infect Control Hosp Epidemiol. 1998;19:188–190
  9. Blot S, Depuydt P, Vogelaers D, Decruyenaere J, De Waele J, Hoste E, et al. Colonization status and appropriate antibiotic therapy for nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in an intensive care unit. Infect Control Hosp Epidemiol. 2005;26:575–579
  10. Bryan CS, Reynolds KL, Brenner ER. Analysis of 1186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy. Rev Infect Dis. 1983;5:629–638
  11. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother. 2005;49:760–766

 Supported by the University of Maryland General Clinical Research Center grant M01 RR 16500, General Clinical Research Centers Program, National Center for Research Resources (NCRR), National Institutes of Health; by the National Institutes of Health (R01 AI60859-01A1 and 1K24AI079040-01A1; to A.D.H.); by National Institutes of Health grant 1K12RR023250-03 (to J.K.J.); and by the University of Maryland Internal Funds (to D.A.R.).

 Conflicts of interest: None to report.

PII: S0196-6553(10)00452-9

doi: 10.1016/j.ajic.2010.03.005

AJIC: American Journal of Infection Control
Volume 38, Issue 9 , Pages 751-753 , November 2010

Article Tools

* Image Usage & Resolution